CNBC partnered with Fintrx to analyze single family offices that made the largest number of investments in private startups in 2024.
Goldman initiates a buy rating on this one-time pandemic stock darling, sees more than 50% upside
A number of catalysts could drive gains for Teladoc Health in the coming months, according to Goldman Sachs.